Avalon GloboCare Corp. Stock News

Columbia Care, Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) is providing an operational update along with

Focused on Novel Combination of Clinical-Grade Exosomes and Hydropeptides for Cosmeceutical and Orthopedic Product DevelopmentSigned Three-Way Material Transfer Agreement.

Avalon Globocare Corp (NASDAQ:AVCO) was the recipient of a significant decline in short interest in March. As of March 31st, there was short interest totalling 779,300 shares, a decline of 8.8% from t

Avalon GloboCare (NASDAQ:AVCO) +44% on advancing immunotherapeutic program towards combatting cytokine storm associated with COVID-19 lung damage and mortality.Safe-T Group Ltd (NASDAQ:SFET) +41% on

Completed Functional Studies of Six QTY Code Designed Variant Cytokine Receptors as “Molecular Mop” to Remove Excessive Cytokines (“Cytokine Storm”) Related to Coronavirus.

Team designs antibody-like receptor proteins that can bind to cytokines, as possible strategy for treating coronavirus and other infections. One of the defining features of Covid-19 is the excessive i

El cineasta, responsable de la imagen de ‘E.T., el extraterrestre’ o ‘El imperio del sol’, ha fallecido en la residencia de la Fundación de Cine y Televisión, donde según ‘The Hollywood R

The market gained almost 9% in the week of 2 April until 8 April. Investors with much cash on hand can keep cautiously buying high-quality stocks. Mimicking ins

FREEHOLD, N.J., Feb. 24, 2020 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that it.

FREEHOLD, N.J., Feb. 04, 2020 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, announced today that its.

It is not uncommon to see companies perform well in the years after insiders buy shares. Unfortunately, there are also...

FREEHOLD, N.J., Jan. 06, 2020 -- Avalon GloboCare Corp. (NASDAQ: AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today announced its Chief.

Forms Major Regional Hub in China for CellTech IndustryPartnership Delivers Synergy of Infrastructural Resources for Clinical Development and Bioprocessing Technologies in.

FREEHOLD, NJ / ACCESSWIRE / November 20, 2019 / Avalon GloboCare Corp. (NASDAQ:AVCO), a leading global developer of cell-based technologies and therapeutics, today announced that management will prese

The big shareholder groups in Avalon GloboCare Corp. (NASDAQ:AVCO) have power over the company. Large companies...